-
Je něco špatně v tomto záznamu ?
Novel CRTC1::MRTFB(MKL2) Gene Fusion Detected in Myxoid Mesenchymal Neoplasms With Myogenic Differentiation Involving Bone and Soft Tissues
LM. Warmke, CD. Collier, PJ. Niziolek, JL. Davis, YS. Zou, M. Michal, RC. Bell, MLC. Policarpio-Nicolas, YW. Cheng, L. Duckworth, JK. Dermawan, KJ. Fritchie, CA. Dehner
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, kazuistiky
NLK
Free Medical Journals
od 2000 do Před 1 rokem
Open Access Digital Library
od 2000-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1988
- MeSH
- buněčná diferenciace * MeSH
- dospělí MeSH
- fúze genů MeSH
- fúzní onkogenní proteiny genetika MeSH
- lidé MeSH
- nádorové biomarkery genetika analýza MeSH
- nádory kostí * genetika patologie MeSH
- nádory měkkých tkání * genetika patologie MeSH
- senioři MeSH
- trans-aktivátory genetika MeSH
- transkripční faktory * genetika MeSH
- vývoj svalů genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
Appropriate classification of fusion-driven bone and soft tissue neoplasms continues to evolve, often relying on the careful integration of morphologic findings with immunohistochemical, molecular, and clinical data. Herein, we present 3 cases of a morphologically distinct myxoid mesenchymal neoplasm with myogenic differentiation and novel CRTC1::MRTFB (formerly MKL2) gene fusion. Three tumors occurred in 1 male and 2 female patients with a median age of 72 years (range: 28-78). Tumors involved the left iliac bone, the right thigh, and the left perianal region with a median size of 4.0 cm (4.0-7.6 cm). Although 1 tumor presented as an incidental finding, the other 2 tumors were noted, given their persistent growth. At the time of the last follow-up, 1 patient was alive with unresected disease at 6 months, 1 patient was alive without evidence of disease at 12 months after surgery, and 1 patient died of disease 24 months after diagnosis. On histologic sections, the tumors showed multinodular growth and were composed of variably cellular spindle to round-shaped cells with distinct brightly eosinophilic cytoplasm embedded within a myxoid stroma. One tumor showed overt smooth muscle differentiation. Cytologic atypia and mitotic activity ranged from minimal (2 cases) to high (1 case). By immunohistochemistry, the neoplastic cells expressed focal smooth muscle actin, h-caldesmon, and desmin in all tested cases. Skeletal muscle markers were negative. Next-generation sequencing detected nearly identical CRTC1::MRTFB gene fusions in all cases. We suggest that myxoid mesenchymal tumors with myogenic differentiation harboring a CRTC1::MRTFB fusion may represent a previously unrecognized, distinctive entity that involves soft tissue and bone. Continued identification of these novel myxoid neoplasms with myogenic differentiation will be important in determining appropriate classification, understanding biologic potential, and creating treatment paradigms.
Biopticka Laboratory Ltd Plzen Czech Republic
Department of Orthopedic Surgery Indiana University School of Medicine Indianapolis Indiana
Department of Pathology and Laboratory Medicine Cleveland Clinic Cleveland Ohio
Department of Pathology Indiana University School of Medicine Indianapolis Indiana
Department of Pathology Michigan University Ann Arbor Michigan
Department of Pathology The Johns Hopkins Hospital Baltimore Maryland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019907
- 003
- CZ-PrNML
- 005
- 20241024111028.0
- 007
- ta
- 008
- 241015s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.modpat.2024.100518 $2 doi
- 035 __
- $a (PubMed)38763420
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Warmke, Laura M $u Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana
- 245 10
- $a Novel CRTC1::MRTFB(MKL2) Gene Fusion Detected in Myxoid Mesenchymal Neoplasms With Myogenic Differentiation Involving Bone and Soft Tissues / $c LM. Warmke, CD. Collier, PJ. Niziolek, JL. Davis, YS. Zou, M. Michal, RC. Bell, MLC. Policarpio-Nicolas, YW. Cheng, L. Duckworth, JK. Dermawan, KJ. Fritchie, CA. Dehner
- 520 9_
- $a Appropriate classification of fusion-driven bone and soft tissue neoplasms continues to evolve, often relying on the careful integration of morphologic findings with immunohistochemical, molecular, and clinical data. Herein, we present 3 cases of a morphologically distinct myxoid mesenchymal neoplasm with myogenic differentiation and novel CRTC1::MRTFB (formerly MKL2) gene fusion. Three tumors occurred in 1 male and 2 female patients with a median age of 72 years (range: 28-78). Tumors involved the left iliac bone, the right thigh, and the left perianal region with a median size of 4.0 cm (4.0-7.6 cm). Although 1 tumor presented as an incidental finding, the other 2 tumors were noted, given their persistent growth. At the time of the last follow-up, 1 patient was alive with unresected disease at 6 months, 1 patient was alive without evidence of disease at 12 months after surgery, and 1 patient died of disease 24 months after diagnosis. On histologic sections, the tumors showed multinodular growth and were composed of variably cellular spindle to round-shaped cells with distinct brightly eosinophilic cytoplasm embedded within a myxoid stroma. One tumor showed overt smooth muscle differentiation. Cytologic atypia and mitotic activity ranged from minimal (2 cases) to high (1 case). By immunohistochemistry, the neoplastic cells expressed focal smooth muscle actin, h-caldesmon, and desmin in all tested cases. Skeletal muscle markers were negative. Next-generation sequencing detected nearly identical CRTC1::MRTFB gene fusions in all cases. We suggest that myxoid mesenchymal tumors with myogenic differentiation harboring a CRTC1::MRTFB fusion may represent a previously unrecognized, distinctive entity that involves soft tissue and bone. Continued identification of these novel myxoid neoplasms with myogenic differentiation will be important in determining appropriate classification, understanding biologic potential, and creating treatment paradigms.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a transkripční faktory $x genetika $7 D014157
- 650 12
- $a nádory měkkých tkání $x genetika $x patologie $7 D012983
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a nádory kostí $x genetika $x patologie $7 D001859
- 650 12
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a nádorové biomarkery $x genetika $x analýza $7 D014408
- 650 _2
- $a fúzní onkogenní proteiny $x genetika $7 D015514
- 650 _2
- $a fúze genů $7 D050939
- 650 _2
- $a trans-aktivátory $x genetika $7 D015534
- 650 _2
- $a vývoj svalů $x genetika $7 D024510
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Collier, Christopher D $u Department of Orthopedic Surgery, Indiana University School of Medicine, Indianapolis, Indiana
- 700 1_
- $a Niziolek, Paul J $u Department of Radiology and Imaging Sciences, Musculoskeletal Imaging, Indiana University School of Medicine, Indianapolis, Indiana
- 700 1_
- $a Davis, Jessica L $u Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana
- 700 1_
- $a Zou, Ying S $u Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland
- 700 1_
- $a Michal, Michael $u Biopticka Laboratory Ltd, Plzen, Czech Republic
- 700 1_
- $a Bell, Robert C $u Department of Pathology, Michigan University, Ann Arbor, Michigan
- 700 1_
- $a Policarpio-Nicolas, Maria Luisa C $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
- 700 1_
- $a Cheng, Yu-Wei $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
- 700 1_
- $a Duckworth, Lauren $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
- 700 1_
- $a Dermawan, Josephine K $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
- 700 1_
- $a Fritchie, Karen J $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
- 700 1_
- $a Dehner, Carina A $u Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana. Electronic address: cadehner@iu.edu
- 773 0_
- $w MED00003380 $t Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc $x 1530-0285 $g Roč. 37, č. 7 (2024), s. 100518
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38763420 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111022 $b ABA008
- 999 __
- $a ok $b bmc $g 2202240 $s 1231880
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 37 $c 7 $d 100518 $e 20240517 $i 1530-0285 $m Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc $n Mod Pathol $x MED00003380
- LZP __
- $a Pubmed-20241015